U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

CEFPIMIZOLE

MORE DETAILS

  24S58UHU7N

Status:
Possibly Marketed Outside US
Source:
Japan:Cefpimizole Sodium
Source URL:
https://tripod.nih.gov/npc/#Download
Class (Stereo):
CHEMICAL (ABSOLUTE)
Conditions:
Uncomplicated gonorrhea
10
Obstetric and gynecologic infections
2
Cefpimizole is an antibiotic of broad spectrum developed in Japan for the treatment of such conditions as uncomplicated gonorrhea and gynecologic infections. The drug was tested in clinical trials, however, its development was terminated.

CEFPIMIZOLE SODIUM

MORE DETAILS

  X4628IMC52

Status:
Possibly Marketed Outside US
Source:
Japan:Cefpimizole Sodium
Source URL:
https://tripod.nih.gov/npc/#Download
Class (Stereo):
CHEMICAL (ABSOLUTE)
Conditions:
Uncomplicated gonorrhea
10
Obstetric and gynecologic infections
2
Cefpimizole is an antibiotic of broad spectrum developed in Japan for the treatment of such conditions as uncomplicated gonorrhea and gynecologic infections. The drug was tested in clinical trials, however, its development was terminated.
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966